Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epitope-vaccine as a new strategy against HIV-1 mutation.

Immunology letters - 1 May 2001

Xiao Y, Lu Y, Chen Y H

Abstract excerpt

An effective vaccine is urgently needed to stop AIDS-epidemic. Up to now none of the candidate HIV-vaccines has been developed to prevent HIV-1 infection. A few neutralizing antibodies against HIV-1 enveloping proteins proved to be highly effective to neutralize different strains in vitro. Unfort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to HIV Infections
Share to AIDS Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes, B-Lymphocyte

Share to Gene Products, env

Share to HIV Antigens

Share to Neutralization Tests

Source

Identifiers

PMID: 11348663
DOI: 10.1016/s0165-2478(01)00187-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026. Prepared record publication-11348663-2026-08-31.1. Manifest publication-graph-cohort-2026-08-31.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 31 Aug 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epitope-vaccine as a new strategy against HIV-1 mutation.PMID 11348663Read ↗

Epitope-vaccine strategy against HIV-1: today and tomorrow.Semantic proximity Read ↗

An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype CSemantic proximity Read ↗

ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.Semantic proximity Read ↗

[Designing an effective AIDS vaccine: strategies and current status].Semantic proximity Read ↗

The neutralizing epitope ELDKWA on HIV-1 gp41: genetic variability and antigenicity.Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.Semantic proximity Read ↗

Progress toward active or passive HIV-1 vaccination.Semantic proximity Read ↗

Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.Semantic proximity Read ↗

Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.Semantic proximity Read ↗

[HIV vaccine: how far along are we?]Semantic proximity Read ↗

Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.